On September 9, 2026 Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") reported that Dr. Christian Behrenbruch, Managing Director and Group CEO and Kevin Richardson, CEO, Precision Medicine will present at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference, both in New York, NY.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details:

Morgan Stanley 24th Annual Global Healthcare Conference
Date: September 14, 2026
Time: 9:15 a.m. EDT (11:15 p.m. AEST)

H.C. Wainwright 28th Annual Global Investment Conference
Date: September 15, 2026
Time: 10:30 a.m. EDT (12:30 a.m. AEST, Sep 16)

Both sessions will be webcast live, and accessible through Telix’s Investor Relations website.

For more information including how to register, please visit: View Source

(Press release, Telix Pharmaceuticals, SEP 9, 2026, View Source [SID1234670677])